Benchmark reissued their buy rating on shares of CareCloud (NASDAQ:CCLD – Free Report) in a research report report published on Monday, Benzinga reports. Benchmark currently has a $3.50 price target on the stock.
Separately, Maxim Group raised CareCloud from a hold rating to a buy rating and set a $3.00 target price for the company in a report on Friday, March 22nd.
Get Our Latest Research Report on CCLD
CareCloud Price Performance
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in CCLD. Dimensional Fund Advisors LP acquired a new position in shares of CareCloud during the 2nd quarter worth $258,000. Northern Trust Corp purchased a new stake in CareCloud during the 2nd quarter worth about $153,000. Geode Capital Management LLC purchased a new stake in CareCloud during the 2nd quarter worth about $225,000. Franklin Resources Inc. purchased a new stake in CareCloud during the 2nd quarter worth about $1,023,000. Finally, BlackRock Inc. purchased a new stake in CareCloud during the 2nd quarter worth about $187,000. Institutional investors and hedge funds own 10.16% of the company’s stock.
About CareCloud
CareCloud, Inc, a healthcare information technology (IT) company, provides a suite of cloud-based solutions and related business services to healthcare providers and hospitals primarily in the United States. It operates in two segments, Healthcare IT and Medical Practice Management. The company's portfolio of proprietary software and business services includes technology-enabled business solutions; cloud-based software; digital health services; healthcare IT professional services and staffing; and medical practice management services.
See Also
- Five stocks we like better than CareCloud
- What is the S&P 500 and How It is Distinct from Other Indexes
- Best Bear Market Funds: Top 3 Investment Options to Consider
- 3 REITs to Buy and Hold for the Long Term
- Is DraftKings A Good Bet Ahead of Q1 Earnings?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Mid-Cap Stocks to Outperform the Market This Cycle
Receive News & Ratings for CareCloud Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareCloud and related companies with MarketBeat.com's FREE daily email newsletter.